Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Chr. Hansen Holding A/S
  6. News
  7. Summary
    CHR   DK0060227585


Real-time Estimate Quote. Real-time Estimate Cboe Europe - 12/03 10:59:45 am
485 DKK   -1.76%
12/02CHR HANSEN A/S : Q1 Aide memoire 2021/22
12/01CHR HANSEN A/S : Fermentation-enabled bioprotection secures Chr. Hansen innovation award
11/26CHR HANSEN A/S : AGM 2021 Votes cast
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Chr Hansen A/S : . Hansen and UPL announce a long-term collaboration to develop and commercialize...

10/15/2021 | 08:52am EST
The new partnership will mean better, targeted products that can go to market faster.
Press Release | Oct 14. 2021 06:40 GMT

Chr. Hansen is joining forces with global agricultural solutions provider UPL in a unique partnership to strengthen the existing portfolio of microbial products and provide farmers with sustainable choices beyond conventional agricultural products.

Biological solutions are becoming more and more in demand as the agriculture industry faces challenges such as the growing resistance to chemicals and an increasingly challenging regulatory environment. Developing biostimulants and biopesticides is an important step in providing sustainable crop protection while increasing farmers' yield and productivity.

The best of both worlds
Under the terms of the partnership, Chr. Hansen will develop biological products based on their microbial capabilities and UPL will register and commercialize these products via its extensive global distribution network.

According to Vicente Gongora, chief marketing officer at UPL Ltd., "Biosolutions are a core pillar of our global purpose and work to reimagine sustainability - for food systems, for farmers, and for our environment. Building on the launch of NPP [Natural Plant Protection - a new global business unit] earlier in the year, we are proud to partner with Chr. Hansen to further expand our portfolio of products and technologies - and to offer new and sustainable solutions for more farming communities.

Consolidating our distribution networks and R&D facilities alongside Chr. Hansen's unique microbial experience and expertise presents a powerful opportunity to change the game for farmers and for sustainable agriculture globally. We look forward to sharing more news on the biological solutions that we are developing for the future, and we are excited about the legacy we will build together."

"UPL is a significant distributor of biosolutions worldwide," says Kim Müller Christensen, vice president of Plant Health at Chr. Hansen. "Combining that with Chr. Hansen's significant innovations in research and development, as well as our unique microbial capabilities and ability to breed our own bacteria, will mean better, targeted products that can go to market faster. The partnership is an important step in our 2025 strategy of growing a better world naturally."

In the best interests of farmers
The Chr. Hansen-UPL partnership has already identified several projects relevant to farmers globally and aims to develop a product pipeline for most major crops that will enable farmers to fight crop diseases and increase their yields. The companies expect the first registrations by the end of 2022.

"In essence the collaboration aims to establish a product pipeline that has the best interests of the famers at heart," says Kim Müller Christensen.

About UPL
UPL Ltd. (NSE: UPL & BSE: 512070) is a global provider of sustainable agriculture products & solutions, with annual revenue exceeding $5 billion. We are a purpose-led company. Through OpenAg, UPL is focused on facilitating progress for the entire agricultural value chain. We are building a network that redefines the way an entire industry thinks and works - open to fresh ideas, innovative ways and new answers as we strive towards our mission to make every single food product more sustainable.

As one of the largest agriculture solutions companies worldwide, our robust portfolio consists of biologicals and traditional crop protection solutions with more than 13,600 registrations. We are present in more than 130 countries, represented by more than 10,000 colleagues globally. For more information about our integrated portfolio of solutions across the food value chain including seeds, post-harvest, as well as physical and digital services, please visit upl-ltd.com.

Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 145 years to enable sustainable agriculture, cleaner labels and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 40,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As the world's most sustainable biotech company, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose - To grow a better world. Naturally. - is at the heart of everything we do.


Chr. Hansen Holding A/S published this content on 14 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 October 2021 12:51:04 UTC.

ę Publicnow 2021
All news about CHR. HANSEN HOLDING A/S
12/02CHR HANSEN A/S : Q1 Aide memoire 2021/22
12/01CHR HANSEN A/S : Fermentation-enabled bioprotection secures Chr. Hansen innovation award
11/26CHR HANSEN A/S : AGM 2021 Votes cast
11/25CHR. HANSEN HOLDING A/S : Ex-dividend day for final dividend
11/24Resolutions passed at the Annual General Meeting of Chr. Hansen Holding A/S
11/24Chr. Hansen Holding A/S Approves Dividend
11/16CHR HANSEN A/S : SWEETY« Y-3 culture adds new, fermentation-powered capabilities to Chr. H..
11/15CHR HANSEN A/S : . Hansen launches science-based climate targets and embarks on a focused...
11/10Lonza JV Bacthera, Seres to Jointly Produce Potential Gut Infection Treatment
11/10Bacthera and Seres Therapeutics Collaborate for Commercial Manufacturing of SER-109, a...
More news
Analyst Recommendations on CHR. HANSEN HOLDING A/S
More recommendations
Sales 2022 1 153 M 1 305 M 1 305 M
Net income 2022 231 M 261 M 261 M
Net Debt 2022 881 M 998 M 998 M
P/E ratio 2022 277x
Yield 2022 0,19%
Capitalization 63 860 M 9 701 M 72 302 M
EV / Sales 2022 56,2x
EV / Sales 2023 52,6x
Nbr of Employees 3 702
Free-Float 77,8%
Duration : Period :
Chr. Hansen Holding A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHR. HANSEN HOLDING A/S
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 13
Last Close Price 485,00 €
Average target price 70,12 €
Spread / Average Target -85,5%
EPS Revisions
Managers and Directors
Mauricio Graber President & Chief Executive Officer
Lise Skaarup Mortensen Chief Financial Officer & Executive Vice President
Dominique Reiniche Chairman
Thomas Schńfer Chief Scientific Officer & Executive VP
Winnie Hojvang BŘgel VP-Compliance & Corporate Communications